LAHORE GENERAL HOSPITAL
šµš°Pakistan
Clinical Trials
15
Active:4
Completed:4
Trial Phases
4 Phases
Early Phase 1:2
Phase 1:1
Phase 2:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)ā¢ Click on a phase to view related trials
Not Applicable
7 (63.6%)Early Phase 1
2 (18.2%)Phase 1
1 (9.1%)Phase 2
1 (9.1%)Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo
Not Applicable
Active, not recruiting
- Conditions
- Vitiligo
- Interventions
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Lahore General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT07044141
- Locations
- šµš°
Lahore general.hospital, Lahore, Punjab, Pakistan
Comparison of Once-Weekly Trelagliptin Vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes
Not Applicable
Active, not recruiting
- Conditions
- Type 2 Diabetes Mellitus (T2DM)
- Interventions
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Lahore General Hospital
- Target Recruit Count
- 102
- Registration Number
- NCT06889909
- Locations
- šµš°
Lahore General Hospital, Lahore, Lahore, Punjab, Pakistan
Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure
Not Applicable
Active, not recruiting
- Conditions
- Acute Liver FailureDrug-Induced Liver Injury
- Interventions
- Other: Standard supportive care
- First Posted Date
- 2025-03-12
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Lahore General Hospital
- Target Recruit Count
- 62
- Registration Number
- NCT06872372
- Locations
- šµš°
Lahore General Hospital, Lahore, Lahore, Punjab, Pakistan
Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial
Not Applicable
Active, not recruiting
- Conditions
- Schizophrenia DisordersPsychotic Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Lahore General Hospital
- Target Recruit Count
- 76
- Registration Number
- NCT06838104
- Locations
- šµš°
Lahore General Hospital, Lahore, Lahore, Punjab, Pakistan
Exercise Training Versus Ropinirole in Treating Restless Legs Syndrome Among Hemodialysis Patients
Not Applicable
Completed
- Conditions
- HemodialysisRestless Legs SyndromeESRD (End Stage Renal Disease)Diabetes Complications
- Interventions
- Other: Excercise training
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Lahore General Hospital
- Target Recruit Count
- 84
- Registration Number
- NCT06468371
- Locations
- šµš°
Lahore General Hospital, Lahore, Lahore, Punjab, Pakistan
- Prev
- 1
- 2
- 3
- Next
News
No news found